Cargando…
Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4
BACKGROUND: Adenylate kinase is a key enzyme in the high-energy phosphoryl transfer reaction in living cells. An isoform of this enzyme, adenylate kinase 4 (AK4), is localized in the mitochondrial matrix and is believed to be involved in stress, drug resistance, malignant transformation in cancer, a...
Autores principales: | Fujisawa, Koichi, Terai, Shuji, Takami, Taro, Yamamoto, Naoki, Yamasaki, Takahiro, Matsumoto, Toshihiko, Yamaguchi, Kazuhito, Owada, Yuji, Nishina, Hiroshi, Noma, Takafumi, Sakaida, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793738/ https://www.ncbi.nlm.nih.gov/pubmed/26980435 http://dx.doi.org/10.1186/s13046-016-0322-2 |
Ejemplares similares
-
Adenylate Kinase Isozyme 3 Regulates Mitochondrial Energy Metabolism and Knockout Alters HeLa Cell Metabolism
por: Fujisawa, Koichi, et al.
Publicado: (2022) -
Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
por: Yamamoto, Naoki, et al.
Publicado: (2016) -
Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging
por: Fujisawa, Koichi, et al.
Publicado: (2015) -
Correction: Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging
por: Fujisawa, Koichi, et al.
Publicado: (2015) -
An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells
por: Fujisawa, Koichi, et al.
Publicado: (2022)